Background: Following ablation therapy for cardiac arrhythmias, patients may develop
| INTRODUCTION
Catheter-based ablation therapies for atrial fibrillation (AF) are part of the current guidelines recommended by major international cardiovascular societies. 1 Ablation is a complex and technically challenging procedure, requiring pulmonary vein isolation and extensive ablation in the left atrium. Because of the proximity of the left atrium to the esophagus, atrioesophageal fistula or esophageal ulceration as a result of direct injury to the adjacent esophagus has been reported as rare complications of catheter ablation procedures.
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In addition, the vagus nerve and its branches are anatomically close to the posterior wall of the left atrium and the pulmonary veins ( Figure 1 ), 5 which are the principal sites of radiofrequency ablation (RFA) in AF. 6, 7 The periesophageal vagus nerve plexus supplies parasympathetic control to the motor functions of the stomach, digestive tract, and gallbladder. 8, 9 Therefore, vagus nerve injury resulting from ablation therapy for AF may rarely lead to motor disorders such as gastroesophageal reflux and gastric hypomotility as a result of the dysfunction or injury of the vagus nerve. 5, 10, 11 A recent multinational survey documented the incidence, clinical course over a short follow up period, and outcomes. 12 However, there are limitations of such survey-based data with limited follow-up, and the methods of diagnosis for functional gastrointestinal (GI) complications such as gastroparesis are not standardized in such multi-center studies. Some of these limitations are overcome in a single center study especially if the sample size is large and the methods of treatment and diagnosis are standardized.
Our objectives were to identify among patients who underwent ablation treatment for AF at Mayo Clinic the occurrence of structural or functional complications in upper gastrointestinal (UGI) tract, to appraise clinical outcomes, review the association with vagal dysfunction, the probable mechanism of the functional UGI complication.
| MATERIALS AND METHODS

| Study design
This study was approved by Mayo Clinic Institutional Review
Board (IRB No. 15-009264). All patients included in this study
provided written consent to use their medical records for research purposes.
| Method for case identification
We tried to identify UGI complications among patients who underwent RFA or cryoablation for atrial fibrillation at Mayo Clinic between 1999 and early 2016.
Firstly, from the AF ablation database of the Cardiac
Electrophysiology Laboratory of Mayo Clinic, Rochester, MN, relevant data were collected prospectively pre-ablation. Patients received a 1 month phone follow-up inquiring for complications and current health status. At 3 months and yearly following the ablation procedure, questionnaires that included: quality of life assessment, recent symptom information, and self-reports of arrhythmia recurrences were requested from the patients. The database includes information about patients who underwent catheter ablation therapy and completed the post-procedural patient questionnaire. We identified patients whose questionnaire responses and additional review of medical records showed they developed any GI symptoms and/ or underwent diagnostic tests following catheter ablation for AF because of clinical concern that there may be damage in the upper GI tract.
Secondly, we used a natural language processing to interrogate electronic medical records of all adults to identify AF ablation patients who had developed any GI symptoms and underwent objective diagnostic tests in the gastroenterology clinic.
After identification, we categorized patients into three groups:
1.
Patients with structural complications (e.g. any esophageal injury)
confirmed by diagnostic tests;
2.
Patients with functional GI complications (any GI symptoms without associated structural problem) confirmed by objective motility test;
3.
Patients with UGI symptoms and no relevant diagnostic tests.
| Method for assessing vagal function
A 12-lead electrocardiogram was performed in all patients, not only in those with GI symptoms, to evaluate heart rhythm after ablation therapy in order to check on the heart rhythm response to the ablation therapy. With the patient in the supine position, a 12-lead electrocardiogram was recorded and displayed in conventional form on paper, run at a speed of 25 mm/s. Using the electrocardiogram tracing, with at least 10 QRS complexes evaluable, we sought evidence of sinus arrhythmia, which was defined as variation in the R-R interval by ≥0.12 seconds (120 milliseconds) in the presence of normal sinus P waves and constant P-R interval assessed by manual measurement. 13 The absence of sinus arrhythmia was used as evidence of vagal dysfunction. We examined electrocardiograms in the medical record for the absence of sinus arrhythmia on 1st day of ablation therapy and at 2nd-3rd months following ablation therapy.
| RESULTS
| Gastrointestinal manifestations
The overall incidence of UGI complications following AF ablation was 0.74% (40/5380). Patients were identified from two search strategies.
Firstly, from the AF ablation database consisting of 5380 patients, we identified 27 patients, of whom 16 had only UGI symptoms. Second,
Key Points
• Following ablation therapy for atrial fibrillation (AF), patients may develop upper gastrointestinal (UGI) symptoms secondary to structural damage or vagal nerve dysfunction affected by the ablation energy.
• We aimed to identify the structural or functional complications in UGI tract following ablation for atrial fibrillation (AF) and clinical outcomes and association with vagal dysfunction.
• Table 2 .
Among the 15 patients who underwent gastrointestinal motility tests for evaluation of unexplained UGI symptoms after ablation therapy for AF, nine patients had newly developed upper GI symptoms, which resolved in all patients. Six patients had recent aggravation of previous upper GI symptoms; two patients (#7 and 11) with dysphagia prior to the intervention were diagnosed with esophageal achalasia and their symptoms resolved after pneumatic balloon dilatation or esophageal myotomy; the remaining three patients had previously diagnosed membranous glomerulonephritis (#9), systemic amyloidosis (#12), and asthma (#15) respectively. Finally, one patient (#2) was diagnosed with vasomotor dysfunction during work-up for UGI symptoms. Upper GI symptoms persisted in two patients (#2 and 12) who had evidence of autonomic dysfunction.
Among nine patients who underwent gastric emptying scintigraphy, three women had delayed gastric emptying, four men had accelerated gastric emptying, and two women normal gastric emptying.
Clinical manifestations of UGI symptoms without diagnostic results
There were 17 patients with UGI symptoms without relevant diagnostic results (Table 3) . Seven patients suffered from swallowing discomfort and 6 had nausea and/or vomiting. Most symptoms resolved over time in 15 patients.
Unfortunately, two patients (#16 and 17) with suspected atrioesophageal fistula or esophageal rupture died at 4 weeks and 5 weeks after the ablation procedure. Patient #16, a 47-year old man experienced heartburn after the ablation procedure. Chest CT and esophagogram performed 2 weeks after ablation therapy showed no specific abnormal findings. However, he presented abruptly to another
The positions of the left atrium, trachea and main stem bronchi, esophagus, and vagus nerve are shown. 5 There are many vagal nerve fibers (shown in yellow) that cross the esophagus close to the regions relevant to ablation of bundles of conducting fibers in the left atrium. Thus, the vagus nerve and its branches are anatomically close to the posterior wall of the left atrium and the pulmonary vein, and may be injured during ablation treatment required to normalize cardiac arrhythmias such as atrial fibrillation hospital with septic shock due to bacteremia and GI bleeding. Patient #17, who was a 71 year old man, experienced mild dysphagia and pleuritic chest pain; chest CT showed no specific abnormal findings;
he also presented to another hospital acutely with septic shock and streptococcal bacteremia about 5 weeks after the RFA procedure.
| Electrocardiogram evidence of sinus arrhythmia after ablation therapy
In five patients, electrocardiograms were not available for review at day 1 and 2-3 months post-ablation. Assessing the data available ( 
| DISCUSSION
Radiofrequency and cryoablation for atrial fibrillation can be lifesaving procedures that can also prevent important complications particularly embolization resulting in stroke. Here, we record that, among 5380 patients who underwent catheter ablation of the conducting pathways in the left atrial posterior wall that result in AF, a very small minority (0.74%, 40 patients) developed structural or functional complications in the UGI tract. The course of UGI complications ranges from mild to severe, and rarely fatal. Our experience is consistent with a recent multicenter, randomized trial to compare the cryoballoon ablation therapy with radiofrequency ablation; this trial showed only one patient with esophageal ulcer and two patients with unknown cause of death and sepsis. 14 In the prior literature (summarized in Table 5 ), there is limited information about vagal nerve injury or abnormal motor functions, such as gastroparesis or esophageal dysmotility. In our study, 13 patients underwent EGD after ablation therapy and seven patients had esophageal erosions and/or ulcers.
Among those seven patients, three patients were asymptomatic.
Previous prospective observational studies suggested that the prevalence for asymptomatic esophageal ulcer or erythema ranged from 3.8 to 14.6%. 10, 15 However, another prospective observational study showed 47.0% prevalence of esophageal ulcer or erythema with correlation between reflux-like symptoms and esophageal wall change. 16 Therefore, it is important for clinicians to suspect such complications especially if patients are symptomatic, or develop unexplained or occult bleeding.
In our study, one patient with a pneumopericardial fistula had no mucosal lesion on EGD on the 18th day after ablation therapy and another patient with suspicious atrio-esophageal fistula had no mucosal defects on EGD on the second day after ablation therapy. Thus, screening for localized esophageal lesion by EGD might be insufficient to predict the risk of significant delayed complications such as atrioesophageal fistula.
Our study demonstrates the development of de novo or aggravation of symptoms suggestive of functional GI morbidity in patients after undergoing ablation therapy for AF. The prevalence of such symptoms appears to be very low and two of the patients' There were 13 patients with limited information of electrocardiogram for sinus arrhythmia after ablation therapy (four with pacemakers, two with AV block, two with recurrent atrial fibrillation, and five with no follow-up ECG).
N=40 1 day after ablation therapy 2-3 months after ablation therapy Interpretation
T A B L E 4
Electrocardiogram evidence of sinus arrhythmia after ablation therapy symptoms were proven to be caused by achalasia. The studies on extra-esophageal autonomic dysfunction in idiopathic achalasia have reported contradictory results. [16] [17] [18] [19] [20] Kravitz et al. showed, in the opossum, that extrinsic vagal damage induced by thoracic vagotomy at the level of heart eliminated esophageal peristalsis and LES relaxation by swallowing, consistent with findings in achalasia. 21 However, Herreros et al. demonstrated that there were no differences in autonomic cardiovascular tests and pancreatic response to vagal stimulus between patients with idiopathic achalasia and healthy controls. 22 Therefore, it remains unclear whether the achalasia diagnosed on two of our series was a result of the effects of the cardiac intervention which would be expected to affect the extrinsic neural supply to the esophagus, rather than the intrinsic inhibitory nerves in the myenteric plexus of the esophagus and lower esophageal sphincter, which are considered the prime disorders innervation that result in achalasia.
Among the other patients in this category of functional GI problems associated with impaired motor functions, the symptoms were generally reversible over time, except in two patients one of whom had evidence of more general autonomic dysfunction and one systemic amyloidosis, which were likely the result of the generalized neuropathy rather than the effects of the RFA ablation on local innervation of the UGI tract. Another prospective observational study showed that 74% patients had at least one new abnormal UGI function test. 27 It is presumed that tissue edema or microhematomas affecting the neighboring mediastinal structures during ablation therapy may have caused compression of the vagus nerve, resulting in injury. Therefore, the presence of vagal nerve injury could provide useful information about possible periesophageal injury that may predispose to esophageal fistula with an adjacent organ. Thus, it is advisable to seek for the evidence of vagal nerve injury even though the patients may have no GI symptoms.
The risks to vagal injury could be reduced by the same techniques used to prevent other esophageal complications, such as esophageal temperature monitoring and mechanical esophageal displacement. 36, 37 However, several recent studies showed no correlation of esophageal temperature monitoring and esophageal damage. 
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